⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Novodiax, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Novodiax, Inc.
↗Hayward, USA
Novodiax is a biotechnology company specializing in the development of innovative tissue-based diagnostics and rapid immunoassays. The company's proprietary polymer-based detection system, including its ihcDirect® technology, enables rapid immunohistochemistry (IHC) results, often in as little as 10 minutes, which is particularly valuable for intraoperative testing in Mohs surgery and surgical oncology.
Beyond its core diagnostic product lines, Novodiax provides contract services for companion diagnostic (CDx) development and partners with pharmaceutical and biotechnology companies to integrate its sensitive detection technologies into drug discovery and development workflows.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Diagnostics
Sub-Industry:Tissue-based diagnostics, Immunohistochemistry (IHC)
SIZE & FINANCIALS
Employees:1-50
Revenue:$10M-$15M
Founded:2008
Ownership:private
Status:operating
FUNDING
Stage:Unknown
Total Raised:$2.3M
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Immunohistochemistry, Immunoassays
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Sino Biological (Webinar/Collaboration), Bio-Connect (Distribution)
COMPETITION
Position:Niche Player
Competitors:SurModics, Accellix, Spear Bio
LEADERSHIP
Key Executives:
Jianfu Wang - CEO & Co-Founder
Jin Wu - VP of Innovation
Scientific Founders:Jianfu Wang, Song Qing Zhao
LINKS
Website:novodiax.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Novodiax, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.